Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

High platelet counts in essential thrombocythemia (ET) can be effectively lowered by treatment with either anagrelide or hydroxyurea. In 259 previously untreated, high-risk patients with ET, diagnosed according to the World Health Organization classification system, the efficacy and tolerability of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gisslinger, Heinz, Gotic, Mirjana, Holowiecki, Jerzy, Penka, Miroslav, Thiele, Juergen, Kvasnicka, Hans-Michael, Kralovics, Robert, Petrides, Petro E., Gastl, G., Gisslinger, B., Muellauer, L., Schlögl, E., Indrak, K., Pytlik, R., Briere, J., Kiladjian, J.J., Beykirch, M., Gaede, B., Griesshammer, M., Herbrik-Zipp, M., Hurtz, H.J., Jacobs, G., Jäcki, S.H., Keilholz, U., Mezger, J., Schlag, P., Schriever, F., Masszi, T., Sacchi, S., Griniptì, R., Tavoriene, I., Dmoszynska, A., Hellman, A., Jedrzejczak, W.W., Robak, T., Skotnicki, A., Goh, Y.T., Cernelc, P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2013
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591796/
https://ncbi.nlm.nih.gov/pubmed/23315161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-07-443770
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares